Dermatology clinical trials recruiting in Pennsylvania

33 recruiting dermatology trials match in Pennsylvania. Showing 20.

• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)Recruiting

  Phase 4 · Eli Lilly and Company · Plymouth Meeting, Pennsylvania

• A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe EczemaRecruiting

  Phase 3 · Pfizer · Huntington Beach, California

• A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque PsoriasisRecruiting

  Phase 2 · InventisBio Co., Ltd · Birmingham, Alabama

• Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis ResearchRecruiting

  N/A · University of Pittsburgh · Pittsburgh, Pennsylvania

• A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic ArthritisRecruiting

  Phase 4 · CARE ARTHRITIS LTD. · Philadelphia, Pennsylvania

• A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic DermatitisRecruiting

  Phase 2 · Hoffmann-La Roche · Minneapolis, Minnesota

• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 2 · Apollo Therapeutics Ltd · Camp Hill, Pennsylvania

• Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Recruiting

  Phase 2 · Merck Sharp & Dohme LLC · Duncansville, Pennsylvania

• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)Recruiting

  Phase 3 · Bristol-Myers Squibb · Camp Hill, Pennsylvania

• A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic DermatitisRecruiting

  Phase 2 · Apogee Therapeutics, Inc. · Pittsburgh, Pennsylvania

• Study of SFA002 in Patients with Mild to Moderate Psoriasis PlaquesRecruiting

  Phase 1 · SFA Therapeutics · Philadelphia, Pennsylvania

• A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar PustulosisRecruiting

  Phase 2 · LEO Pharma · Philadelphia, Pennsylvania

• A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic ArthritisRecruiting

  Phase 2 · Janssen Research & Development, LLC · Philadelphia, Pennsylvania

• A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to DupilumabRecruiting

  Phase 3 · AbbVie · Philadelphia, Pennsylvania

• Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic ArthritisRecruiting

  Phase 2 · AbbVie · Duncansville, Pennsylvania

• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruiting

  Phase 1 · National Cancer Institute (NCI) · Pittsburgh, Pennsylvania

• Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe AcneRecruiting

  Phase 1 / Phase 2 · Sanofi Pasteur, a Sanofi Company · Camp Hill, Pennsylvania

• A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesRecruiting

  Phase 3 · Takeda · Duncansville, Pennsylvania

• A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesRecruiting

  Phase 3 · Takeda · Wyomissing, Pennsylvania

• Observational Study of Pediatric Rheumatic Diseases: The CARRA RegistryRecruiting

  N/A · Duke University · Hershey, Pennsylvania

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.